Vanda eyes first FDA-approved delayed sleep-wake disorder drug0ShareHealthVanda eyes first FDA-approved delayed sleep-wake disorder drug10 sources·Updated Oct 1, 2026·1 min read0Photo: Artem Podrez / Wikimedia Commons (Pexels)SponsoredSponsoredIn this story:🏷️VandaTagWhere do you stand?VandaSupportOpposeMore on this storyBack to NewsBusinessGoldman Executives Expected to Receive $500 Million BonusesGoldman Sachs is preparing more than $500 million in special stock awards for about 20 senior executives, with CEO David Solomon set to receive more than $100 million.14 sourcesFinanceInternational Bancshares Plans Texas Exchange ListingTexas Capital Bancshares began trading on the Texas Stock Exchange after moving its primary listings from Nasdaq, with its tickers expected to change in November. International Bancshares also plans to move its listing to TXSE, starting Oct. 19 under ticker IBOC, as both companies cite their deep Texas ties.
